DN

DNA Group (T.R.) Ltd.

DNA | TA

Overview

Corporate Details

ISIN(s):
IL0011038523
LEI:
Country:
Israel
Address:
Shimon Hatars' 43, 6249245 Tel Aviv
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

DNA Group develops and markets technological solutions for defense and homeland security sectors.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2022-11-06 14:35
Regulatory News Service
Changes in the company's names and security names , effective as of f November …
Hebrew (modern) 149.0 KB
2021-07-29 21:13
Regulatory News Service
Termination of coverage report
Hebrew (modern) 174.5 KB
2021-07-29 21:13
Notice of Dividend Amount
Termination of coverage report
Russian 101.2 KB
2021-06-13 10:10
Regulatory News Service
update Analysis (FROST) following financial report, target price remains at NIS…
English 1.1 MB
2021-06-13 10:10
Investor Presentation
update Analysis (FROST) following financial report, target price remains at NIS…
Russian 101.2 KB
2021-04-11 22:23
Earnings Release
update Analysis (FROST) following financial report 2020,target price remains at…
English 1.1 MB
2021-04-11 22:23
Pre-Annual General Meeting Information
update Analysis (FROST) following financial report 2020,target price remains at…
Russian 98.1 KB
2020-12-16 19:22
Investor Presentation
Analysis update following financial report:price target is unchanged NIS 2.62
English 1.1 MB
2020-12-16 19:22
Investor Presentation
Analysis update following financial report:price target is unchanged NIS 2.62
Russian 94.7 KB
2020-09-01 21:58
Regulatory News Service
Analysis update following financial report:price target is unchanged NIS 2.62
English 1.1 MB
2020-09-01 21:58
Environmental & Social Information
Analysis update following financial report:price target is unchanged NIS 2.62
Russian 94.7 KB
2020-08-24 21:06
Earnings Release
update analsis (FORST),price target is unchanged
English 1.1 MB
2020-08-24 21:06
Investor Presentation
update analsis (FORST),price target is unchanged
Russian 91.4 KB
2020-06-10 21:16
Investor Presentation
Quarterly analysis update report
English 1.1 MB
2020-06-10 21:16
Investor Presentation
Quarterly analysis update report
Russian 93.5 KB

Automate Your Workflow. Get a real-time feed of all DNA Group (T.R.) Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for DNA Group (T.R.) Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Delta Drone Logo
Develops proprietary drone tech for logistics, security & military and consolidates the industry.
France ALDR
DexTech Medical AB Logo
Developing pharmaceuticals for urological oncology using its proprietary GuaDex technology platform.
Sweden DEX
DG INNOVATE PLC Logo
Develops sustainable tech for EV drivetrains and next-gen energy storage materials.
United Kingdom DGI
Dicot Pharma AB Logo
Developing next-gen potency drugs for erectile dysfunction and premature ejaculation.
Sweden DICOTBT
Elanix Biotechnologies AG Logo Germany ELN
E-Novia Logo
A deep-tech factory building Physical AI ventures for mobility, logistics, and automation.
Italy E9IA
EUROESPES Logo
Research & patient care for CNS diseases via personalized genomic medicine.
Spain EEP
Eurofins-Cerep Logo
CRO offering preclinical drug profiling, screening & pharmacology testing for pharma/biotech.
France ALECR
Evotec SE Logo
A drug discovery and development partner for pharma, biotech, and academia.
Germany EVT
FARON PHARMACEUTICALS OY Logo
Develops myeloid cell-targeting immunotherapies for solid and hematological cancers.
Finland FARN

Talk to a Data Expert

Have a question? We'll get back to you promptly.